Officials REJECT a 'game-changing' cancer drug for NHS patients

Simon Stevens, the chief executive of NHS England, said the advantages of the new drugs was 'potentially huge'. NHS watchdog NICE has now issued draft guidance rejecting one of the drugs - larotrectinib.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news